Press Releases | DEA.gov
Pasar al contenido principal
U.S. flag

Un sitio oficial del Gobierno de Estados Unidos

Así es como usted puede verificarlo

Dot gov
Los sitios web oficiales usan .gov
Un sitio web .gov pertenece a una organización oficial del Gobierno de Estados Unidos.
Https

Los sitios web seguros .gov usan HTTPS
Un candado ( Candado Un candado cerrado ) o https:// significa que usted se conectó de forma segura a un sitio web .gov. Comparta información sensible sólo en sitios web oficiales y seguros.

  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
      • Operational Divisions
    • DEA Museum
    • Wall of Honor
    • Contáctenos
      • Submit a Tip
      • Extortion Scam
      • Public Affairs
      • Social Media Directory
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
      • Fee Waiver
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
      • Human Trafficking Prevention

United States Drug Enforcement Administration

  • Recibir Actualizaciones
  • Scam Alert
  • Menú Completo
  • English
  • Español

Main Menu

Explore DEA
  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
    • DEA Museum
    • Wall of Honor
    • Contáctenos
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas

Press Releases

Advanced Search

Enter Keywords Below

Filter Results

Select To Narrow Search Results

Year

  • 2025 (22)
  • 2024 (24)
  • 2023 (51)
  • 2022 (88)
  • 2021 (67)
  • 2020 (8)
  • 2019 (6)
  • 2018 (1)
  • 2017 (3)
  • 2016 (1)
  • 2003 (1)

Subject

  • Drug Trafficking (4010)
  • Synthetic drugs (1064)
  • Guns/Weapons (989)
  • OCDETF/Task Force (810)
  • Fake Pills (654)
  • Arrests/Convictions - Major (603)
  • Guilty Plea (529)
  • Seizures (Drugs/Property) (456)
  • Prescription Drugs (364)
  • Overdose (321)
  • Major Law Enforcement Operation (267)
  • Take Back Day (246)
  • Diversion Division (242)
  • Task Forces/Task Force Officers (230)
  • Money Laundering (203)
  • Gangs (196)
  • Outreach/Drug Prevention (184)
  • Fentanyl Awareness (152)
  • One Pill Can Kill (110)
  • HIDTA (103)
  • Press Conferences (68)
  • Narcoterrorism (53)
  • Prevention/Education - DEA websites GSAD, JTT etc (53)
  • Extraditions (50)
  • Dark Web- Internet Trafficking (29)
  • Asset Forfeiture (28)
  • International/Foreign Operations (28)
  • Red Ribbon (27)
  • Congressional Affairs (15)
  • Terrorism (14)
  • Fentanyl Free America (12)
  • Intergovernmental Affairs (9)
  • Other (8)
  • Campaigns (7)
  • Critical Incident (6)
  • Counterfeit Pills (5)
  • Intelligence Division - Intelligence Products (5)
  • Scam Calls (5)
  • Museum and Visitors Center (3)
  • El Paso Intelligence Center (2)
  • Recruitment/Office of Training/Graduations (2)
  • Pharmaceuticals/Pharmacists/Physicians (224)
  • Public and Media Affairs - also see Congressional Affairs (50)

Drug Name

  • Oxycodone (48)
  • Opioids (47)
  • Fentanyl (36)
  • Synthetic Opioids (14)
  • Hydromorphone (12)
  • Methamphetamine (8)
  • Benzodiazepines (7)
  • Morphine (7)
  • Cocaine (3)
  • Ketamine (3)
  • Methadone (3)
  • Steroids (3)
  • Amphetamines (2)
  • GHB (1)
  • Heroin (1)

Field Division

  • Washington, DC (43)
  • St. Louis (32)
  • Sede (26)
  • New York (24)
  • Chicago (19)
  • Miami (17)
  • New Jersey (14)
  • El Paso (13)
  • Atlanta (12)
  • Dallas (8)
  • New Orleans (8)
  • Houston (7)
  • Omaha (7)
  • San Francisco (7)
  • Seattle (7)
  • Louisville (5)
  • New England (5)
  • San Diego (5)
  • Los Angeles (4)
  • Rocky Mountain (4)
  • Phoenix (2)
  • Caribe (1)
  • Detroit (1)
  • Philadelphia (1)
Clear All Results
PRESS RELEASE

DEA’s Commitment to Expanding Access to Medication-Assisted Treatment

Marzo 23, 2022
WASHINGTON – Today, Administrator Anne Milgram announced the Drug Enforcement Administration’s continued commitment to expanding access to medication-assisted treatment to help those suffering from substance use disorder. “In this moment, when the United States is suffering tens of thousands of opioid-related overdose deaths every year, the DEA’s top priority is...
Marzo 23, 2022
PRESS RELEASE

Former Pain Clinic Doctor Sentenced to Two Years in Federal Prison for Money Structuring

Marzo 17, 2022
TAMPA, Fla. – On March 16, 2022, Dr. Zachary Bird (51, Tampa) was sentenced to 24 months in federal prison, followed by 1 year of supervised release, for structuring cash transactions to evade bank reporting requirements. As part of his sentence, the Court also entered a money judgment in the...
Marzo 17, 2022
PRESS RELEASE

Pharmacy Owner Convicted of Unlawfully Dispensing 1.5 Million Doses of Controlled Substances

Marzo 08, 2022
Houston-A federal jury in the Southern District of Texas convicted a Texas pharmacy owner yesterday for unlawfully distributing controlled substances and laundering money from his now-shuttered pharmacies. According to court documents and evidence presented at trial, Clint Carr, 32, of Cypress, co-owned and operated CC Pharmacy in Houston, and CC...
Marzo 08, 2022
PRESS RELEASE

DEA Chicago Suspends Registration Number of Suburban Chicago Physician

Marzo 04, 2022
CHICAGO – Robert Bell, Special Agent in Charge of the U.S. Drug Enforcement Administration - Chicago Division, announced that on March 3, 2022, DEA Chicago Diversion Investigators served an Immediate Suspension Order on Faris Abusharif, M.D., for allegedly committing acts that render the continued use of his DEA Registration inconsistent...
Marzo 04, 2022
PRESS RELEASE

Former Nurse at Danville Hospital Sentenced for Tampering with Prescription Opioid Drugs, Making False Statements

Marzo 04, 2022
DANVILLE, Va. – A former registered nurse working at Sovah Health-Danville was sentenced today to 36 months in federal prison for tampering with consumer products (fentanyl and hydromorphone) and making false statements. Emilee Kathryn Poteat, 31, pleaded guilty in May 2021 to one count of tampering with consumer products (fentanyl...
Marzo 04, 2022
PRESS RELEASE

Brian S. Besser Named Special Agent in Charge of the Denver Field Division

Marzo 04, 2022
DENVER – Administrator Anne Milgram has named Brian Besser as the Special Agent in Charge of the Denver Field Division. Besser most recently served as the Interim Assistant Administrator over the Diversion Control Division at DEA headquarters in Washington. As the Special Agent in Charge, Besser will lead a staff...
Marzo 04, 2022
PRESS RELEASE

DEA Administrator names Greg Millard as SAC of the El Paso Division

Marzo 02, 2022
EL PASO – The Drug Enforcement Administration’s El Paso Division has a new Special Agent in Charge (SAC). On Friday Feb. 18, 2022, DEA Administrator Anne Milgram named Greg Millard as the new SAC of the El Paso Division, which serves New Mexico and West Texas. Millard came to El...
Marzo 02, 2022
PRESS RELEASE

DEA Washington Joins D.C. Partners to Announce New Partnership Focused on Violent Crime

Febrero 18, 2022
Washington, D.C., -- Today, Jarod Forget, Special Agent in Charge (SAC) of the DEA Washington Division, and Michael Rothermund, Assistant Special Agent in Charge of the DEA Washington Division joined D.C. Mayor Muriel Bowser and Metropolitan Police Department (MPD) Chief Robert J. Contee III to announce a new D.C.-based strategy...
Febrero 18, 2022
PRESS RELEASE

Richland Naturopath Agrees to Pay $70,096 for Improper Prescription of Controlled Substances

Febrero 16, 2022
Richland, Wash. – Judith K. Caporiccio, N.D., a Richland-based naturopathic doctor, has agreed to pay $70,096 to resolve allegations under the Controlled Substances Act and the False Claims Act, which allege that she improperly prescribed controlled substances between July 2016 and July 2021. The Controlled Substances Act regulates certain drugs...
Febrero 16, 2022
PRESS RELEASE

Pharmacist Indicted for Tampering with a Controlled Substance

Febrero 16, 2022
KANSAS CITY, Kan. – A federal grand jury in Kansas City returned an indictment charging a pharmacist with one count of tampering with a consumer product, one count of possession of tramadol by deception and subterfuge, one count of possession of zolpidem by deception and subterfuge, and one count of...
Febrero 16, 2022
Showing 151 - 160 of 272 results

Paginación

  • Primera página «
  • Página anterior ‹
  • Página 12
  • Página 13
  • Página 14
  • Página 15
  • Current page 16
  • Página 17
  • Página 18
  • Página 19
  • Página 20
  • Siguiente página ›
  • Última página »
  • Quienes Somos
    • Sobre
    • Contáctenos
    • Museo DEA
  • Recursos
    • Ley de Libertad de Información (FOIA)
    • Publicaciones
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
  • Políticas
    • Accesibilidad, Complementos y Política
    • Políticas Legales y Descargos de Responsabilidad
    • Antidiscriminación y Represalias Acto
    • Política de Privacidad
    • Política de Igualdad de Oportunidades en el Empleo del U.S. DOJ
    • USA.gov
    • Protección de Denunciantes
    • Your Rights as a Federal Employee

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook X LinkedIn Instagram

DEA Contact Center

(202) 307-1000 info@dea.gov
Contact the Webmaster